CELGENE CORP /DE/ Insider Trading Transactions
Get free email notifications about insider trading for CELGENE CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and 10% Owner in CELGENE CORP /DE/ ($CELG) and 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and in ACCELERON PHARMA INC ($XLRN) and 10% Owner in ACCELERON PHARMA INC ($XLRN) and in SUTRO BIOPHARMA INC ($STRO) and 10% Owner in Abraxis BioScience, Inc. ($ABII) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in CRISPR Therapeutics AG ($CRSP).
Latest Insider Trading Transactions of CELGENE CORP /DE/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 5.88 | 38,979 | 229,197 | 0 | |
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 102.28 | 2,241 | 229,209 | 7,008,510 | 7 M to 7 M (-0.03 %) |
Jul 13 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | X | 5.88 | 38,979 | 229,197 | 7,010,751 | 7 M to 7 M (+0.56 %) |
Jul 13 2020 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 5.88 | 38,979 | 229,197 | 0 | |
Jul 13 2020 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 102.28 | 2,241 | 229,209 | 7,008,510 | 7 M to 7 M (-0.03 %) |
Jul 13 2020 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | X | 5.88 | 38,979 | 229,197 | 7,010,751 | 7 M to 7 M (+0.56 %) |
Jul 13 2020 | BMY | BRISTOL MYERS SQUI ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 5.88 | 38,979 | 229,197 | 0 | |
Jul 13 2020 | BMY | BRISTOL MYERS SQUI ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 102.28 | 2,241 | 229,209 | 7,008,510 | 7 M to 7 M (-0.03 %) |
Jul 13 2020 | BMY | BRISTOL MYERS SQUI ... | CELGENE CORP /DE/ | 10% Owner | Buy | X | 5.88 | 38,979 | 229,197 | 7,010,751 | 7 M to 7 M (+0.56 %) |
Jul 06 2020 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 92.50 | 108,108 | 9,999,990 | 6,971,772 | 6.9 M to 7 M (+1.58 %) |
Jul 06 2020 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 92.50 | 108,108 | 9,999,990 | 6,971,772 | 6.9 M to 7 M (+1.58 %) |
Jul 06 2020 | BMY | BRISTOL MYERS SQUI ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 92.50 | 108,108 | 9,999,990 | 6,971,772 | 6.9 M to 7 M (+1.58 %) |
Nov 14 2019 | AGIO | AGIOS PHARMACEUTIC ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 31.00 | 403,225 | 12,499,975 | 1,777,824 | 1.4 M to 1.8 M (+29.33 %) |
Nov 14 2019 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 31.00 | 403,225 | 12,499,975 | 1,777,824 | 1.4 M to 1.8 M (+29.33 %) |
Jan 22 2019 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | Buy | P | 43.00 | 706,206 | 30,366,858 | 6,824,685 | 6.1 M to 6.8 M (+11.54 %) | |
Jan 22 2019 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Buy | P | 43.00 | 706,206 | 30,366,858 | 6,824,685 | 6.1 M to 6.8 M (+11.54 %) | |
Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,726,075 | 0 | 0 | ||
Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,097,331 | 0 | 0 | ||
Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 2,845,114 | 0 | 0 | ||
Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 8,338,892 | 0 | 0 | ||
Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Buy | C | 0.00 | 1,726,197 | 0 | 1,726,197 | 0 to 1.7 M | |
Oct 02 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,726,075 | 0 | 0 | ||
Oct 02 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,097,331 | 0 | 0 | ||
Oct 02 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 2,845,114 | 0 | 0 | ||
Oct 02 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 8,338,892 | 0 | 0 | ||
Oct 02 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | Buy | C | 0.00 | 1,726,197 | 0 | 1,726,197 | 0 to 1.7 M | |
Jan 23 2018 | AGIO | AGIOS PHARMACEUTIC ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 67.00 | 851,154 | 57,027,318 | 1,374,599 | 523.4 K to 1.4 M (+162.61 %) |
Jan 23 2018 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 67.00 | 851,154 | 57,027,318 | 1,374,599 | 523.4 K to 1.4 M (+162.61 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.47 | 30,485 | 593,543 | 3,722,534 | 3.8 M to 3.7 M (-0.81 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 87,991 | 1,680,628 | 3,753,019 | 3.8 M to 3.8 M (-2.29 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.04 | 12,666 | 241,161 | 3,841,010 | 3.9 M to 3.8 M (-0.33 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 4,263 | 82,063 | 3,853,676 | 3.9 M to 3.9 M (-0.11 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.22 | 5,080 | 97,638 | 3,857,939 | 3.9 M to 3.9 M (-0.13 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.75 | 27,990 | 552,803 | 3,863,019 | 3.9 M to 3.9 M (-0.72 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 20.00 | 26,010 | 520,200 | 3,891,009 | 3.9 M to 3.9 M (-0.66 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.76 | 256,000 | 5,058,560 | 3,917,019 | 4.2 M to 3.9 M (-6.13 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 80,000 | 1,540,000 | 4,173,019 | 4.3 M to 4.2 M (-1.88 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.02 | 158,718 | 3,018,816 | 4,253,019 | 4.4 M to 4.3 M (-3.60 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.44 | 51,282 | 945,640 | 4,411,737 | 4.5 M to 4.4 M (-1.15 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.39 | 105,000 | 1,930,950 | 4,463,019 | 4.6 M to 4.5 M (-2.30 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.67 | 15,000 | 265,050 | 4,568,019 | 4.6 M to 4.6 M (-0.33 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.19 | 14,907 | 256,251 | 4,583,019 | 4.6 M to 4.6 M (-0.32 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.76 | 65,093 | 1,156,052 | 4,597,926 | 4.7 M to 4.6 M (-1.40 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.28 | 10,000 | 172,800 | 4,663,019 | 4.7 M to 4.7 M (-0.21 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.08 | 20,000 | 341,600 | 4,673,019 | 4.7 M to 4.7 M (-0.43 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.06 | 16,875 | 304,763 | 4,693,019 | 4.7 M to 4.7 M (-0.36 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.54 | 23,000 | 426,420 | 4,709,894 | 4.7 M to 4.7 M (-0.49 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.89 | 79,327 | 1,498,487 | 4,732,894 | 4.8 M to 4.7 M (-1.65 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 22,759 | 434,697 | 4,812,221 | 4.8 M to 4.8 M (-0.47 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.47 | 30,485 | 593,543 | 3,722,534 | 3.8 M to 3.7 M (-0.81 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 87,991 | 1,680,628 | 3,753,019 | 3.8 M to 3.8 M (-2.29 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.04 | 12,666 | 241,161 | 3,841,010 | 3.9 M to 3.8 M (-0.33 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 4,263 | 82,063 | 3,853,676 | 3.9 M to 3.9 M (-0.11 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.22 | 5,080 | 97,638 | 3,857,939 | 3.9 M to 3.9 M (-0.13 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.75 | 27,990 | 552,803 | 3,863,019 | 3.9 M to 3.9 M (-0.72 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 20.00 | 26,010 | 520,200 | 3,891,009 | 3.9 M to 3.9 M (-0.66 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.76 | 256,000 | 5,058,560 | 3,917,019 | 4.2 M to 3.9 M (-6.13 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 80,000 | 1,540,000 | 4,173,019 | 4.3 M to 4.2 M (-1.88 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.02 | 158,718 | 3,018,816 | 4,253,019 | 4.4 M to 4.3 M (-3.60 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.44 | 51,282 | 945,640 | 4,411,737 | 4.5 M to 4.4 M (-1.15 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.39 | 105,000 | 1,930,950 | 4,463,019 | 4.6 M to 4.5 M (-2.30 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.67 | 15,000 | 265,050 | 4,568,019 | 4.6 M to 4.6 M (-0.33 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.19 | 14,907 | 256,251 | 4,583,019 | 4.6 M to 4.6 M (-0.32 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.76 | 65,093 | 1,156,052 | 4,597,926 | 4.7 M to 4.6 M (-1.40 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.28 | 10,000 | 172,800 | 4,663,019 | 4.7 M to 4.7 M (-0.21 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.08 | 20,000 | 341,600 | 4,673,019 | 4.7 M to 4.7 M (-0.43 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.06 | 16,875 | 304,763 | 4,693,019 | 4.7 M to 4.7 M (-0.36 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.54 | 23,000 | 426,420 | 4,709,894 | 4.7 M to 4.7 M (-0.49 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.89 | 79,327 | 1,498,487 | 4,732,894 | 4.8 M to 4.7 M (-1.65 %) |
Dec 07 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 22,759 | 434,697 | 4,812,221 | 4.8 M to 4.8 M (-0.47 %) |
Sep 25 2017 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 37.00 | 745,592 | 27,586,904 | 6,118,479 | 5.4 M to 6.1 M (+13.88 %) |
Sep 25 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 37.00 | 745,592 | 27,586,904 | 6,118,479 | 5.4 M to 6.1 M (+13.88 %) |
Apr 13 2017 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 296,277 | 0 | 7,342,377 | 7 M to 7.3 M (+4.20 %) |
Apr 13 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 296,277 | 0 | 7,342,377 | 7 M to 7.3 M (+4.20 %) |
Mar 01 2017 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 0.50 | 4,000,000 | 2,000,000 | 7,046,100 | 3 M to 7 M (+131.32 %) |
Mar 01 2017 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 0.50 | 4,000,000 | 2,000,000 | 7,046,100 | 3 M to 7 M (+131.32 %) |
Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 4,034,830 | 0 | 0 | |
Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 14.00 | 800,150 | 11,202,100 | 4,834,980 | 4 M to 4.8 M (+19.83 %) |
Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 4,034,830 | 0 | 4,034,830 | 0 to 4 M |
Oct 26 2016 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 4,034,830 | 0 | 0 | |
Oct 26 2016 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 14.00 | 800,150 | 11,202,100 | 4,834,980 | 4 M to 4.8 M (+19.83 %) |
Oct 26 2016 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 4,034,830 | 0 | 4,034,830 | 0 to 4 M |
Jan 11 2016 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 40.00 | 800,000 | 32,000,000 | 5,372,887 | 4.6 M to 5.4 M (+17.49 %) |
Jan 11 2016 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 40.00 | 800,000 | 32,000,000 | 5,372,887 | 4.6 M to 5.4 M (+17.49 %) |
May 04 2015 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 4.55 | 659,340 | 2,999,997 | 3,046,100 | 2.4 M to 3 M (+27.62 %) |
May 04 2015 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 4.55 | 659,340 | 2,999,997 | 3,046,100 | 2.4 M to 3 M (+27.62 %) |
May 06 2014 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 42.86 | 1,100,000 | 47,146,000 | 4,572,887 | 3.5 M to 4.6 M (+31.67 %) |
Apr 15 2014 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | A | 10.50 | 142,857 | 1,499,999 | 142,857 | |
Apr 15 2014 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 7.00 | 714,286 | 5,000,002 | 2,386,760 | 1.7 M to 2.4 M (+42.71 %) |
Apr 15 2014 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | A | 10.50 | 142,857 | 1,499,999 | 142,857 | |
Apr 15 2014 | ALQA | Alliqua BioMedical ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 7.00 | 714,286 | 5,000,002 | 2,386,760 | 1.7 M to 2.4 M (+42.71 %) |
May 06 2014 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 42.86 | 1,100,000 | 47,146,000 | 4,572,887 | 3.5 M to 4.6 M (+31.67 %) |
Jan 29 2014 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 50.00 | 300,000 | 15,000,000 | 3,472,887 | 3.2 M to 3.5 M (+9.46 %) |
Jan 29 2014 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 50.00 | 300,000 | 15,000,000 | 3,472,887 | 3.2 M to 3.5 M (+9.46 %) |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 1,990,446 | 0 | 0 | |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | J | 0.00 | 36,496 | 0 | 0 | |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 15.00 | 666,667 | 10,000,005 | 3,172,887 | 2.5 M to 3.2 M (+26.60 %) |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 1,990,446 | 0 | 2,506,220 | 515.8 K to 2.5 M (+385.91 %) |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 57,899 | 0 | 515,774 | 457.9 K to 515.8 K (+12.65 %) |
Sep 26 2013 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 457,875 | 0 to 457.9 K |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 1,990,446 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | J | 0.00 | 36,496 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 15.00 | 666,667 | 10,000,005 | 3,172,887 | 2.5 M to 3.2 M (+26.60 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 1,990,446 | 0 | 2,506,220 | 515.8 K to 2.5 M (+385.91 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | J | 0.00 | 57,899 | 0 | 515,774 | 457.9 K to 515.8 K (+12.65 %) |
Sep 26 2013 | XLRN | ACCELERON PHARMA I ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 457,875 | 0 to 457.9 K |
Oct 18 2010 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | P | 0.00 | 40,735,300 | 0 | 100 | -40,735,200 to 100 (-100.00 %) |
Oct 18 2010 | ABII | Abraxis BioScience ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 0.00 | 40,735,300 | 0 | 100 | -40,735,200 to 100 (-100.00 %) |
Apr 01 2005 | CASI | CASI Pharmaceutica ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 1.50 | 7,000,000 | 10,500,000 | 0 | |
Apr 01 2005 | CASI | CASI Pharmaceutica ... | CELGENE CORP /DE/ | 10% Owner | Buy | X | 1.50 | 7,000,000 | 10,500,000 | 23,750,000 | 16.8 M to 23.8 M (+41.79 %) |
Apr 01 2005 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 1.50 | 7,000,000 | 10,500,000 | 0 | |
Apr 01 2005 | CELG | CELGENE CORP /DE/ | CELGENE CORP /DE/ | 10% Owner | Buy | X | 1.50 | 7,000,000 | 10,500,000 | 23,750,000 | 16.8 M to 23.8 M (+41.79 %) |
Page: 1